Nephros, Inc. (NEPH) vs Precipio, Inc. (PRPO)
A side-by-side comparison of Nephros, Inc. and Precipio, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
NEPH
Nephros, Inc.
$3.49HealthcareDelayed quote: Oct 6, 2026, 2:59 PM EDT
PRPO
Precipio, Inc.
$23.62HealthcareDelayed quote: Oct 6, 2026, 2:52 PM EDT
Total return — NEPH vs PRPO
growth of $100 · dividends reinvested · last 9yNEPH +71.5% (+6.2%/yr)PRPO -99.1% (-40.8%/yr)NEPH compounded faster over this window
Log scale — wide-divergence pair
NEPH PRPO
NEPH vs PRPO: by the numbers
- •PRPO is the larger company ($42M vs $38M market cap).
- •NEPH is profitable (8.38% net margin) while PRPO runs a net loss (-4.42%).
- •PRPO grew revenue faster over the past five years (28.84% vs 16.99% CAGR).
Metrics side by side
Valuation
| Metric | NEPH | PRPO |
|---|---|---|
| P/E ratio | 22.02 | N/A |
| Forward P/E | 22.31 | N/A |
| P/S ratio | 1.83 | 1.53 |
| P/B ratio | 3.17 | 2.85 |
| EV / EBITDA | 19.33 | N/A |
| FCF yield | N/A | 1.87% |
Profitability
| Metric | NEPH | PRPO |
|---|---|---|
| Gross margin | 60.31% | 43.69% |
| Operating margin | 7.92% | -5.63% |
| Net margin | 8.38% | -4.42% |
| ROE | 14.51% | -8.23% |
| ROIC | 12.67% | -8.43% |
Growth (annualized)
| Metric | NEPH | PRPO |
|---|---|---|
| Revenue CAGR (5Y) | 16.99% | 28.84% |
| Total return CAGR (5Y) | -15.93% | -14.46% |
Frequently asked
- Which has grown faster, NEPH or PRPO?
- Over the past five years, PRPO grew revenue faster — NEPH at a 16.99% CAGR versus PRPO at 28.84%.
- Is NEPH or PRPO more profitable?
- NEPH runs the higher net margin — NEPH at 8.38% versus PRPO at -4.42%.
- How have NEPH and PRPO total returns compared?
- Over the past 5 years, NEPH delivered -15.93% and PRPO delivered -14.46% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Nephros P/E ratioNephros ROEPrecipio ROENephros operating marginPrecipio operating marginNephros revenue growthPrecipio revenue growthNephros free cash flowPrecipio free cash flow
Nephros & Precipio appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.